| Literature DB >> 29432948 |
Maud Bollenbach1, Eric Salvat2, François Daubeuf3, Patrick Wagner1, Ipek Yalcin4, Muris Humo4, Baptiste Letellier4, Léa J Becker4, Frédéric Bihel1, Jean-Jacques Bourguignon1, Pascal Villa5, Adeline Obrecht5, Nelly Frossard1, Michel Barrot4, Martine Schmitt6.
Abstract
4-phenylpyridin-2-yl-guanidine (5b): a new inhibitor of the overproduction of pro-inflammatory cytokines (TNFα and Il1β) was identified from a high-throughput screening of a chemical library on human peripheral blood mononuclear cells (PBMCs) after LPS stimulation. Derivatives, homologues and rigid mimetics of 5b were designed and synthesized, and their cytotoxicity and ability to inhibit TNFα overproduction were evaluated. Among them, compound 5b and its mimetic 12 (2-aminodihydroquinazoline) showed similar inhibitory activities, and were evaluated in vivo in models of lung inflammation and neuropathic pain in mice. In particular, compound 12 proved to be active (5 mg/kg, ip) in both models.Entities:
Keywords: Inflammation; Neuropathic pain; Phenotypic screening; Pyridine-2-yl guanidine; TNFα inhibitor
Mesh:
Substances:
Year: 2018 PMID: 29432948 DOI: 10.1016/j.ejmech.2018.01.049
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514